Temporal Trends and Sex Differences in Patients With Cardiac Amyloidosis and Heart Failure With Preserved Ejection Fraction: Retrospective Analysis of 22,015 Admissions From the National Inpatient Sample.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 31 08 2022
accepted: 07 09 2022
pubmed: 14 9 2022
medline: 24 11 2022
entrez: 13 9 2022
Statut: ppublish

Résumé

Cardiac amyloidosis (CA) often goes unrecognized as a cause of heart failure with preserved ejection fraction (HFpEF). There is paucity of contemporary data evaluating the trends of CA diagnosis and associated sex differences. Adult heart failure hospitalizations were identified from the National Inpatient Sample between 2016 and 2019. Hospitalizations with heart failure other than HFpEF were excluded. Hospitalizations with a diagnosis of CA were identified. A Linear regression was utilized to calculate the trend of CA diagnosis over time. A multivariate logistic regressions analysis was performed to analyze sex differences. There was an increasing trend of CA from 1.2 to 2.3 per 1000 HFpEF admission in the first quarter of 2016 to the fourth quarter of 2019 (P

Identifiants

pubmed: 36100096
pii: S0146-2806(22)00290-0
doi: 10.1016/j.cpcardiol.2022.101393
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101393

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Ahmed Maraey (A)

Department of Internal Medicine, University of North Dakota Southwest Campus, Bismarck, ND; Department of Hospital Medicine, CHI St. Alexius Health, Bismarck, ND.

Constantine Tarabanis (C)

Department of Internal Medicine, New York University Langone Health, New York, NY.

Alexander G Hajduczok (AG)

Jefferson Heart Institute, Sidney Kimmel School of Medicine/Thomas Jefferson University, Philadelphia, PA.

Mahmoud Salem (M)

Heart and Vascular institute, University of Pittsburgh Medical Center, Harrisburg, PA.

Ebram Said (E)

Department of Cardiology, Beni Suef University Hospital, Beni Suef, Egypt.

Hadeer Elsharnoby (H)

Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL.

Mahmoud Khalil (M)

Department of Internal Medicine, Lincoln Medical Center, Bronx, NY.

Ahmed Elzanaty (A)

Department of Cardiovascular Medicine, University of Toledo, Toledo, OH.

Yevgeniy Brailovsky (Y)

Jefferson Heart Institute, Sidney Kimmel School of Medicine/Thomas Jefferson University, Philadelphia, PA.

Amit Alam (A)

Center for Advanced Heart and Lung Diseases, Baylor University Medical Center, Dallas, TX. Electronic address: Amit.Alam@bswhealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH